RARRES2 and metabolic dysfunction-associated steatotic liver disease: Elevated serum chemerin levels have been observed in various inflammatory diseases, such as non-alcoholic fatty liver disease (NAFLD), rheumatoid arthritis, and bowel inflammatory conditions [46,47,48].